排序方式: 共有12条查询结果,搜索用时 15 毫秒
1.
Invasive breast carcinomas with ATM gene variants of uncertain significance share distinct histopathologic features
下载免费PDF全文
![点击此处可从《The breast journal》网站下载免费的PDF全文](/ch/ext_images/free.gif)
Ahmed A. Abdulrahman MD Rebecca C. Heintzelman MD Melanie Corbman MS LCGC Fernando U. Garcia MD 《The breast journal》2018,24(3):291-297
The increasing availability of next‐generation sequencing for clinical research dramatically improved our understanding of breast cancer genetics and resulted in detection of new mutation variants. Cancer risk data relating to some of these variants are insufficient, prompting the designation of variants of uncertain significance (VUS). The histopathologic characteristics of these variants have not been previously described. We propose to depict these characteristics and determine if invasive carcinomas with similar VUS genes share similar histomorphologic features. In total, 28 invasive breast cancers with VUS were retrospectively identified. Tumor sections were reviewed and a predefined set of histopathologic characteristics were documented and compared. Nine of the 28 cases were variants in the ATM gene and were found to share similar histologic characteristics; all had tumor cells with low nuclear grade, absent tumor infiltrating lymphocytes, as well as a marked desmoplastic response. A subset of the above findings were identified in variants of other genes but none had all findings collectively. Furthermore, variants of ATM gene had smaller tumor size, lower pathologic T stage at presentation, and more favorable surrogate molecular subtype compared to variants of other genes. These findings could potentially be used to reclassify VUS and predict which patients may harbor ATM mutations, and hence could have implications in triaging toward ATM variant identification for potential future targeted therapy. 相似文献
2.
Melissa A. Alderfer PhD Kristin Zelley MS LCGC Robert B. Lindell MD Ana Novokmet BA Phuong L. Mai MD MS Judy E. Garber MD MPH Deepika Nathan MS CGC Sarah Scollon MS CGC Nicolette M. Chun MS LCGC Andrea F. Patenaude PhD James M. Ford MD Sharon E. Plon MD PhD Joshua D. Schiffman MD Lisa R. Diller MD Sharon A. Savage MD David Malkin MD Carol A. Ford MD Kim E. Nichols MD 《Cancer》2015,121(2):286-293
3.
4.
Understanding of multigene test results among males undergoing germline testing for inherited prostate cancer: Implications for genetic counseling
下载免费PDF全文
![点击此处可从《The Prostate》网站下载免费的PDF全文](/ch/ext_images/free.gif)
5.
Universal screening of both endometrial and colon cancers increases the detection of Lynch syndrome
下载免费PDF全文
![点击此处可从《Cancer》网站下载免费的PDF全文](/ch/ext_images/free.gif)
6.
7.
Adeline Vanderver MD Cas Simons PhD Guy Helman BS Joanna Crawford MS Nicole I. Wolf MD PhD Geneviève Bernard MD Amy Pizzino MS GCG Johanna L. Schmidt MPH MGC Asako Takanohashi DVM PhD David Miller BAppSc Amirah Khouzam MS MA CGC Vani Rajan MS Erica Ramos MS LCGC Shimul Chowdhury PhD Tina Hambuch PhD Kelin Ru MS Gregory J. Baillie PhD Sean M. Grimmond PhD Ljubica Caldovic PhD Joseph Devaney PhD Miriam Bloom MD Sarah H. Evans MD Jennifer L. P. Murphy MS CPNP‐AC Nathan McNeill MS Brent L. Fogel MD PhD the Leukodystrophy Study Group Raphael Schiffmann MD Marjo S. van der Knaap MD PhD Ryan J. Taft PhD 《Annals of neurology》2016,79(6):1031-1037
Here we report whole exome sequencing (WES) on a cohort of 71 patients with persistently unresolved white matter abnormalities with a suspected diagnosis of leukodystrophy or genetic leukoencephalopathy. WES analyses were performed on trio, or greater, family groups. Diagnostic pathogenic variants were identified in 35% (25 of 71) of patients. Potentially pathogenic variants were identified in clinically relevant genes in a further 7% (5 of 71) of cases, giving a total yield of clinical diagnoses in 42% of individuals. These findings provide evidence that WES can substantially decrease the number of unresolved white matter cases. Ann Neurol 2016;79:1031–1037 相似文献
8.
Mary K. Ladd MA Beth N. Peshkin MS CGC Claudine Isaacs MD Gillian Hooker PhD ScM LCGC Shawna Willey MD Heiddis Valdimarsdottir PhD Tiffani DeMarco MS CGC Suzanne O'Neill PhD Savannah Binion BS Marc D. Schwartz PhD other members of the Surgery After Genetic Evaluation Study Group 《Journal of surgical oncology》2020,122(2):134-143
9.
10.
Zeynep Eroglu MD Shifra Krinshpun MS LCGC Ekaterina Kalashnikova PhD Sumedha Sudhaman PhD Turkan Ozturk Topcu MD Matt Nichols BS Justin Martin MS Katherine M. Bui MD Charuta C. Palsuledesai PhD Meenakshi Malhotra PhD Perry Olshan MA PhD Joseph Markowitz MD PhD Nikhil I. Khushalani MD Ahmad A. Tarhini MD PhD Jane L. Messina MD Alexey Aleshin MD MBA 《Cancer》2023,129(11):1723-1734